Corcept Therapeutics Incorporated (CORT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Corcept Therapeutics Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$86.28
−1.50% today
Market cap
$9.5B
Overall quality
72/100
Kronos AI 30-day
+30.4%
8 of 8 simulated paths end higher
Corcept Therapeutics Incorporated (CORT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $9.5B. It trades at $86.28, down 1.50% today, at 172.7 times earnings. Its overall quality score is 72 out of 100, ranked against the whole US market. 5 analysts' average target of $141.00 implies +63.4% from today's price. Kronos AI's 30-day forecast is +30.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $141.00 |
| Low – high | $50.00 – $165.00 |
| Analysts | 5 |
| Upside to average | +63.4% |
Kronos AI 30-day forecast
| Expected close | $114.17 (+30.4%) |
| Likely range | +11.0% … +33.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 61 |
| Solvency | 84 |
| Growth | 72 |
| Overall | 72 |
| P/E | 172.7 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.